UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials

The European respiratory journal, 2016-01, Vol.47 (1), p.243-253

2016

Volltextzugriff (PDF)

Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease

The European respiratory journal, 2016-02, Vol.47 (2), p.588-596

2016

Volltextzugriff (PDF)

Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views

Respiration, 2018-11, Vol.96 (6), p.514-524

2018

Volltextzugriff (PDF)

Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease

Journal of rheumatology, 2013-05, Vol.40 (5), p.640-646

2013

Volltextzugriff (PDF)

Sarcoidosis-related Mortality in the United States from 1988 to 2007

American journal of respiratory and critical care medicine, 2011-06, Vol.183 (11), p.1524-1530

2011

Volltextzugriff (PDF)

Rheumatoid Arthritis―Interstitial Lung Disease―associated Mortality

American journal of respiratory and critical care medicine, 2011-02, Vol.183 (3), p.372-378

2011

Volltextzugriff (PDF)

Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis

The lancet respiratory medicine, 2017-01, Vol.5 (1), p.33-41

2017

Volltextzugriff (PDF)

High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival

Respiratory medicine, 2017-05, Vol.126, p.100-104

2017

Volltextzugriff (PDF)

The Clinical Course of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia

Chest, 2015-02, Vol.147 (2), p.415-422

2015

Volltextzugriff (PDF)

A Multidisciplinary Evaluation Helps Identify the Antisynthetase Syndrome in Patients Presenting as Idiopathic Interstitial Pneumonia

Journal of rheumatology, 2016-05, Vol.43 (5), p.887-892

2016

Volltextzugriff (PDF)

Pulmonary Function and Survival in Idiopathic vs Secondary Usual Interstitial Pneumonia

Chest, 2014-09, Vol.146 (3), p.775-785

2014

Volltextzugriff (PDF)

Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003

American journal of respiratory and critical care medicine, 2007-08, Vol.176 (3), p.277-284

2007

Volltextzugriff (PDF)

Patient-Reported Outcomes in Idiopathic Pulmonary Fibrosis Research

Chest, 2012-08, Vol.142 (2), p.291-297

2012

Volltextzugriff (PDF)

A first look at the reliability, validity and responsiveness of L-PF-35 dyspnea domain scores in fibrotic hypersensitivity pneumonitis

BMC pulmonary medicine, 2024-04, Vol.24 (1), p.188-8, Article 188

2024

Volltextzugriff (PDF)

The SF-36 and SGRQ: Validity and first look at minimum important differences in IPF

Respiratory medicine, 2010-02, Vol.104 (2), p.296-304

2010

Volltextzugriff (PDF)

Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases

European respiratory review, 2018-12, Vol.27 (150), p.180075

2018

Volltextzugriff (PDF)

Managing Cough in Idiopathic Pulmonary Fibrosis

Chest, 2021-11, Vol.160 (5), p.1774-1782

2021

Volltextzugriff (PDF)

The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis

Respiratory medicine, 2012-10, Vol.106 (10), p.1447-1455

2012

Volltextzugriff (PDF)

Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?

BMJ open respiratory research, 2023-07, Vol.10 (1), p.e001546

2023

Volltextzugriff (PDF)

Idiopathic Pulmonary Fibrosis: Diagnosis and Epidemiology

Clinics in chest medicine, 2012-03, Vol.33 (1), p.41-50

2012

Volltextzugriff (PDF)

Increased Risk of Pulmonary Embolism Among US Decedents With Sarcoidosis From 1988 to 2007

Chest, 2011-11, Vol.140 (5), p.1261-1266

2011

Volltextzugriff (PDF)

Idiopathic pulmonary fibrosis: Educational needs of health-care providers, patients, and caregivers

Chronic respiratory disease, 2019-01, Vol.16, p.1479973119858961-1479973119858961

2019

Volltextzugriff (PDF)

Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung disease

BMJ open respiratory research, 2023-09, Vol.10 (1), p.e001872

2023

Volltextzugriff (PDF)

Informal caregivers experience of supplemental oxygen in pulmonary fibrosis

Health and quality of life outcomes, 2017-07, Vol.15 (1), p.133-133, Article 133

2017

Volltextzugriff (PDF)

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(164)

Publikationsform

Artikel
(190)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials

Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease

Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views

Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease

Sarcoidosis-related Mortality in the United States from 1988 to 2007

Rheumatoid Arthritis―Interstitial Lung Disease―associated Mortality

Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis

High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival

The Clinical Course of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia

A Multidisciplinary Evaluation Helps Identify the Antisynthetase Syndrome in Patients Presenting as Idiopathic Interstitial Pneumonia

Pulmonary Function and Survival in Idiopathic vs Secondary Usual Interstitial Pneumonia

Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003

Patient-Reported Outcomes in Idiopathic Pulmonary Fibrosis Research

A first look at the reliability, validity and responsiveness of L-PF-35 dyspnea domain scores in fibrotic hypersensitivity pneumonitis

The SF-36 and SGRQ: Validity and first look at minimum important differences in IPF

Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases

Managing Cough in Idiopathic Pulmonary Fibrosis

Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial

The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis

Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?

Idiopathic Pulmonary Fibrosis: Diagnosis and Epidemiology

Increased Risk of Pulmonary Embolism Among US Decedents With Sarcoidosis From 1988 to 2007

Idiopathic pulmonary fibrosis: Educational needs of health-care providers, patients, and caregivers

Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung disease

Informal caregivers experience of supplemental oxygen in pulmonary fibrosis

Suchergebnisse filtern